Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort

Table 3 Results of univariable logistic regression of variables associated with statin use in 309 participants

Variable	Odds ratio	95 % CI	P-value
Age (per year)	1.01	0.98, 1.04	0.58
Duration of diabetes (per year)	1.02	0.98, 1.06	0.38
Female	0.42	0.24, 0.71	0.001*
Parent with CVD	0.96	0.58, 1.59	0.86
Sibling with CVD	0.63	0.35, 1.13	0.12
History of smoking	1.28	0.77, 2.11	0.34
Physically active	0.86	0.49, 1.5	0.60
History of hypertension	1.69	1.01, 2.82	0.047*
BMI (per kg/m²)	1.1	1.03, 1.18	0.006*
HbA1c (per %)	1.09	0.86, 1.4	0.47
LDL-C (per mmol/L)	0.25	0.15, 0.41	<0.001*
HDL-C (per mmol/L)	0.44	0.26, 0.77	0.004*
Triglycerides (per mmol/L)	1.2	0.68, 2.15	0.53
Total cholesterol (per mmol/L)	0.35	0.24, 0.5	<0.001*
Microvascular complication^a	2.21	1.19, 4.11	0.01*
Neuropathy	1.14	0.68, 1.89	0.62
Nephropathy	1.89	1.05, 3.39	0.03*
Retinopathy	2.04	1.16, 3.6	0.01*
Absence of CVD history	0.34	0.19, 0.63	<0.001*
ASA	3.44	2.04, 5.8	<0.001*
RASi	2.82	1.66, 4.81	<0.001*
ARB	1.89	1.05, 3.41	0.04*
ACEi	1.7	1.01, 2.86	0.046*

^aPresence of at least one of neuropathy, nephropathy, or retinopathy, based on objective evidence
* Statistically significant p < 0.05

ISSN: 1475-2840